June 25, 2012 (Seattle, Washington)— Many patients on ventricular-assist-device (VAD) support are at such low risk of adverse events that they ought not to be in the highest-priority category for a ...

Please provide your email address to receive an email when new articles are posted on . The FDA designated Abbott’s recall of its LVAD communication system as class I, the most serious type. Status of ...

Abbott is recalling a communication system that monitors heart failure patients implanted with its Heartmate 3 left ventricular assist device (LVAD) due to a risk that the system could unexpectedly ...

BrioHealth Solutions announces it has reached a major milestone with the 100th enrollment in the INNOVATE Trial of the BrioVAD® System, a Left Ventricular Assist Device (LVAD). The BrioVAD® System ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced it has received a breakthrough device designation from the FDA for its fully implantable ...

NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration has granted conditional approval to conduct an Investigational Device Exemption study of Jarvik Heart’s new miniature Left Ventricular ...

The Sandra Atlas Bass Heart Hospital at North Shore University Hospital (NSUH) is the first on Long Island to implant the newest generation of a left ventricular assist device (LVAD) that provides ...

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...

PITTSBURGH, May 21 – Doctors at UPMC have begun a study using an investigational cardiac device, the VentrAssist™ Left Ventricular Assist System (LVAD) to see whether it can be used safely and ...

The advanced heart failure team at Virtua Our Lady of Lourdes Hospital in Camden has successfully performed the health system’s first left ventricular assist device (LVAD) implantation. LVADs are ...

It's been almost a year since St. Jude Medical announced its acquisition of left ventricular assist device (LVAD) maker Thoratec, and the past 12 months have shaken up the LVAD market. Since then, St.

Patients with left ventricular assist devices (LVADs) may benefit from having their pulmonary artery (PA) pressures monitored with the CardioMEMS system (Abbott), a nonrandomized study suggests. In ...